Latest BOXER CAPITAL, LLC Stock Portfolio
$1.90Billion– No. of Holdings #61
BOXER CAPITAL, LLC Performance:
2024 Q2: -8.28%YTD: -1.09%2023: 6.96%
Performance for 2024 Q2 is -8.28%, and YTD is -1.09%, and 2023 is 6.96%.
About BOXER CAPITAL, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Boxer Capital, LLC reported an equity portfolio of $1.9 Billions as of 30 Jun, 2024.
The top stock holdings of Boxer Capital, LLC are RVMD, SWTX, CYTK. The fund has invested 8.8% of it's portfolio in REVOLUTION MEDICINES INC and 6.8% of portfolio in SPRINGWORKS THERAPEUTICS INC.
The fund managers got completely rid off VIKING THERAPEUTICS INC (VKTX) and DIREXION SHS ETF TR (BRZU) stocks. They significantly reduced their stock positions in DBV TECHNOLOGIES S A (DBVT). Boxer Capital, LLC opened new stock positions in ELIEM THERAPEUTICS INC (ELYM), REPLIMUNE GROUP INC (REPL) and CULLINAN THERAPEUTICS INC (CGEM). The fund showed a lot of confidence in some stocks as they added substantially to PROTARA THERAPEUTICS INC (TARA), CENTURY THERAPEUTICS INC (IPSC) and SPYRE THERAPEUTICS INC (AGLE).
The top stock holdings of Boxer Capital, LLC are RVMD, SWTX, CYTK. The fund has invested 8.8% of it's portfolio in REVOLUTION MEDICINES INC and 6.8% of portfolio in SPRINGWORKS THERAPEUTICS INC.
The fund managers got completely rid off VIKING THERAPEUTICS INC (VKTX) and DIREXION SHS ETF TR (BRZU) stocks. They significantly reduced their stock positions in DBV TECHNOLOGIES S A (DBVT). Boxer Capital, LLC opened new stock positions in ELIEM THERAPEUTICS INC (ELYM), REPLIMUNE GROUP INC (REPL) and CULLINAN THERAPEUTICS INC (CGEM). The fund showed a lot of confidence in some stocks as they added substantially to PROTARA THERAPEUTICS INC (TARA), CENTURY THERAPEUTICS INC (IPSC) and SPYRE THERAPEUTICS INC (AGLE).
BOXER CAPITAL, LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2024
BOXER CAPITAL, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Boxer Capital, LLC made a return of -8.28% in the last quarter. In trailing 12 months, it's portfolio return was 5.89%.
New Buys
| Ticker | $ Bought |
|---|---|
| eliem therapeutics inc | 18,508,700 |
| replimune group inc | 13,827,100 |
| cullinan therapeutics inc | 11,473,700 |
| olema pharmaceuticals inc | 7,033,000 |
New stocks bought by BOXER CAPITAL, LLC
Additions
| Ticker | % Inc. |
|---|---|
| protara therapeutics inc | 287 |
| century therapeutics inc | 180 |
| spyre therapeutics inc | 178 |
| iteos therapeutics inc | 63.35 |
Additions to existing portfolio by BOXER CAPITAL, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| dbv technologies s a | -50.00 |
BOXER CAPITAL, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| direxion shs etf tr | -2,551,500 |
| viking therapeutics inc | -24,600,000 |
BOXER CAPITAL, LLC got rid off the above stocks
Sector Distribution
Boxer Capital, LLC has about 94.1% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 94.1 |
| Others | 5.9 |
Market Cap. Distribution
Boxer Capital, LLC has about 9.2% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 48.9 |
| SMALL-CAP | 33.4 |
| UNALLOCATED | 5.9 |
| LARGE-CAP | 5.4 |
| MEGA-CAP | 3.8 |
| MICRO-CAP | 2.4 |
Stocks belong to which Index?
About 71.7% of the stocks held by Boxer Capital, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 71.7 |
| Others | 28.3 |
BOXER CAPITAL, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of BOXER CAPITAL, LLC
Boxer Capital, LLC has 61 stocks in it's portfolio. About 54.3% of the portfolio is in top 10 stocks. SWTX proved to be the most loss making stock for the portfolio. RVMD was the most profitable stock for Boxer Capital, LLC last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABSI | absci corporation | 0.11 | 700,000 | 2,156,000 | unchanged | 0.00 | ||
| AGLE | spyre therapeutics inc | 0.86 | 696,480 | 16,374,200 | added | 178 | ||
| AKRO | akero therapeutics inc | 2.07 | 1,676,730 | 39,336,200 | unchanged | 0.00 | ||
| ALLO | allogene therapeutics inc | 0.47 | 3,850,000 | 8,970,500 | unchanged | 0.00 | ||
| AMLX | amylyx pharmaceuticals inc | 0.15 | 1,500,000 | 2,850,000 | unchanged | 0.00 | ||
| ANAB | anaptysbio inc | 1.72 | 1,300,000 | 32,578,000 | unchanged | 0.00 | ||
| APLS | apellis pharmaceuticals inc | 3.49 | 1,726,000 | 66,209,400 | unchanged | 0.00 | ||
| ARVN | arvinas inc | 0.85 | 608,614 | 16,201,300 | unchanged | 0.00 | ||
| ATRA | atara biotherapeutics inc | 0.07 | 166,000 | 1,411,000 | unchanged | 0.00 | ||
| AXSM | axsome therapeutics inc | 1.70 | 400,000 | 32,200,000 | unchanged | 0.00 | ||
| BCAB | bioatla inc | 0.05 | 686,347 | 940,295 | unchanged | 0.00 | ||
| BDTX | black diamond therapeutics i | 0.12 | 506,000 | 2,357,960 | unchanged | 0.00 | ||
| BGNE | beigene ltd | 3.76 | 500,000 | 71,335,000 | unchanged | 0.00 | ||
| BRZU | direxion shs etf tr | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CGEM | cullinan therapeutics inc | 0.60 | 657,895 | 11,473,700 | new | |||
| CYTK | cytokinetics inc | 5.99 | 2,100,000 | 113,778,000 | unchanged | 0.00 | ||
| DAWN | day one biopharmaceuticals i | 0.86 | 1,189,940 | 16,397,400 | unchanged | 0.00 | ||
| DBVT | dbv technologies s a | 0.01 | 250,000 | 200,250 | reduced | -50.00 | ||
| ELYM | eliem therapeutics inc | 0.98 | 2,603,190 | 18,508,700 | new | |||
| FATE | fate therapeutics inc | 1.42 | 8,215,910 | 26,948,200 | unchanged | 0.00 | ||